Natixis’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,000
Closed -$22.4K 995
2023
Q2
$22.4K Buy
+25,000
New +$22.4K ﹤0.01% 873